中文     русский     Home | Set As Homepage
  
 
   News
Title  Content    
Zizhu’s misoprostol receives WHO prequalification
Time:2016/11/24 8:38:28          Click:3775          Source:zizhu-pharmFont Size:  

Just two months ago, the Coalition extended congratulations to Beijing Zizhu Pharmaceutical Co., Ltd. when its mifepristone product was prequalified by WHO. Today, we are delighted to celebrate another victory for Zizhu, a Coalition member since 2012. Zizhu’s misoprostol 200μg product has just received WHO prequalification, making it the fourth prequalified misoprostol product. Misoprostol is a uterotonic with a varied range of uses including the prevention and treatment of postpartum hemorrhage—a chief cause of maternal deaths.
 
 
    Mifepristone200mg Tablets approved by WHO Prequalification
  First co-pack of mifepristone oral tablet and misoprostol for vaginal administration prequalified
 
Contact:   Tel: +86-10-65483355  Fax: +86-10-62245401
E-Mail:  zizhu@zizhu-pharm.com
China  Resources  Zizhu  Pharmaceutical  Co.,Ltd Home | News | About us | Health & Wellness | Products | R & D | Foreign Affairs
京 ICP备10215952号-2
Copyright© 2011-2021